Home
Groningen Cardiology

Groningen Cardiology Market Share Analysis for August 2026

Nullam id dolor id nibh ultricies vehicula ut id elit. Praesent commodo cursus magna, vel scelerisque nisl consectetur et. Donec sed odio dui. Aenean eu leo quam.

Industry: N/A

Domaingroningencardiology.com

Year Founded1977

Employees51 - 200

Annual Revenue--

Groningen Cardiology

Groningen Cardiology (including company regionals)

groningencardiology.com

See more website traffic and engagement information

Total visits to Groningen Cardiology's top domains

Understand Groningen Cardiology market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

groningencardiology.com672

See more with Sales Intelligence

Avg. visit duration in Groningen Cardiology's top domains

Analyze Groningen Cardiology engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

groningencardiology.com00:02:21

See more with Sales Intelligence

Avg. pageviews on Groningen Cardiology's top domains

See how Groningen Cardiology keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

groningencardiology.com3.43

See more with Sales Intelligence

Groningen Cardiology top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Groningen Cardiology

These are the website technologies, by industry, used by Groningen Cardiology top domains

Email Services (3)

Sendgrid

Mobile (3)

Meta Viewport

Advertising (2)

DoubleClick

Widget (2)

Google Maps

More Technologies

7

See all

News & Signals from Groningen Cardiology

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGroningencardiology receives financing of $2.66M in grant.UMCG Cardiology will receive a €2.5 million grant from the Dutch Heart Foundation for research on atrial fibrillation.